216 related articles for article (PubMed ID: 28420298)
1. Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatment.
Calza L; Colangeli V; Magistrelli E; Rossi N; Rosselli Del Turco E; Bussini L; Borderi M; Viale P
HIV Clin Trials; 2017 May; 18(3):110-117. PubMed ID: 28420298
[TBL] [Abstract][Full Text] [Related]
2. Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia.
Tesfaye DY; Kinde S; Medhin G; Megerssa YC; Tadewos A; Tadesse E; Shimelis T
Diabetes Metab Syndr; 2014; 8(2):102-7. PubMed ID: 24907175
[TBL] [Abstract][Full Text] [Related]
3. Association of HIV-infection, antiretroviral treatment and metabolic syndrome with large artery stiffness: a cross-sectional study.
Msoka TF; Van Guilder GP; Smulders YM; van Furth M; Bartlett JA; van Agtmael MA
BMC Infect Dis; 2018 Dec; 18(1):708. PubMed ID: 30594160
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Metabolic Syndrome in Patients with HIV in the Era of Highly Active Antiretroviral Therapy.
Lombo B; Alkhalil I; Golden MP; Fotjadhi I; Ravi S; Virata M; Lievano M; Diez J; Ghantous A; Donohue T
Conn Med; 2015 May; 79(5):277-81. PubMed ID: 26245015
[TBL] [Abstract][Full Text] [Related]
7. Influences of gender in metabolic syndrome and its components among people living with HIV virus using antiretroviral treatment in Hawassa, southern Ethiopia.
Hirigo AT; Tesfaye DY
BMC Res Notes; 2016 Mar; 9():145. PubMed ID: 26945987
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
Feleke Y; Fekade D; Mezegebu Y
Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy.
Hansen BR; Petersen J; Haugaard SB; Madsbad S; Obel N; Suzuki Y; Andersen O
HIV Med; 2009 Jul; 10(6):378-87. PubMed ID: 19490178
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinical correlates of metabolic syndrome in Nigerians living with human immunodeficiency virus/acquired immunodeficiency syndrome.
Ayodele OE; Akinboro AO; Akinyemi SO; Adepeju AA; Akinremi OA; Alao CA; Popoola AA
Metab Syndr Relat Disord; 2012 Oct; 10(5):373-9. PubMed ID: 22799758
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America.
Alvarez C; Salazar R; Galindez J; Rangel F; Castaãeda ML; Lopardo G; Cuhna CA; Roldan Y; Sussman O; Gutierrez G; Cure-Bolt N; Seas C; Carcamo C; Castrillo M
Braz J Infect Dis; 2010; 14(3):256-63. PubMed ID: 20835509
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of metabolic syndrome among HIV-infected patients in Ghana: A cross-sectional study.
Obirikorang C; Quaye L; Osei-Yeboah J; Odame EA; Asare I
Niger Med J; 2016; 57(2):86-90. PubMed ID: 27226681
[TBL] [Abstract][Full Text] [Related]
13. Metabolic and body composition changes after six months of highly active antiretroviral therapy in northern Indian patients.
Gupta V; Biswas A; Sharma SK
Int J STD AIDS; 2011 Jan; 22(1):46-9. PubMed ID: 21364067
[TBL] [Abstract][Full Text] [Related]
14. Metabolic disorders and cardiovascular risk in people living with HIV/AIDS without the use of antiretroviral therapy.
Raposo MA; Armiliato GNA; Guimarães NS; Caram CA; Silveira RDS; Tupinambás U
Rev Soc Bras Med Trop; 2017; 50(5):598-606. PubMed ID: 29160505
[TBL] [Abstract][Full Text] [Related]
15. The burden of metabolic diseases amongst HIV positive patients on HAART attending The Johannesburg Hospital.
Julius H; Basu D; Ricci E; Wing J; Basu JK; Pocaterra D; Bonfanti P
Curr HIV Res; 2011 Jun; 9(4):247-52. PubMed ID: 21631427
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors of metabolic syndrome in HIV-infected adults at three urban clinics in a post-conflict setting, eastern Democratic Republic of the Congo.
Katoto PDMC; Thienemann F; Bulabula ANH; Esterhuizen TM; Murhula AB; Lunjwire PPM; Bihehe DM; Nachega JB
Trop Med Int Health; 2018 Jul; 23(7):795-805. PubMed ID: 29752857
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Syndrome in Children and Adolescents Living with HIV.
Espiau M; Yeste D; Noguera-Julian A; González-Tomé MI; Falcón-Neyra L; Gavilán C; Navarro-Gómez ML; Mellado-Peña MJ; Gracia-Casanova M; Colino-Gil ME; Méndez M; Ciria Calavia LM; Fortuny C; Carrascosa A; Soler-Palacín P;
Pediatr Infect Dis J; 2016 Jun; 35(6):e171-6. PubMed ID: 26910591
[TBL] [Abstract][Full Text] [Related]
18. Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients.
Dave JA; Levitt NS; Ross IL; Lacerda M; Maartens G; Blom D
PLoS One; 2016; 11(3):e0151911. PubMed ID: 26986065
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of metabolic syndrome among human immunodeficiency virus-infected subjects is widely influenced by the diagnostic criteria.
Cubero JM; Domingo P; Sambeat M; Ordoñez-Llanos J; Rodriguez-Espinosa J; Sánchez-Quesada JL; Pérez A
Metab Syndr Relat Disord; 2011 Oct; 9(5):345-51. PubMed ID: 21542770
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome in French HIV-infected patients: prevalence and predictive factors after 3 years of antiretroviral therapy.
Biron A; Bobin-Dubigeon C; Volteau C; Piroth L; Perré P; Leport C; Prazuck T; Jovelin T; Billard M; Sébille V; Bard JM; Raffi F; Biron C
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1672-8. PubMed ID: 22731114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
